Fawcett leads a team of communicators who produce targeted, innovative communication for the Rogel Cancer Center’s research and clinical enterprises. Prior to Michigan Medicine, Fawcett was a reporter at the Detroit News and editor for a web-based community for people with disabilities.
A genetic mutation makes a glioma subtype resistant to radiation, but a new study finds a potential way around it using currently available drugs.
Up to one-third of primary care providers discussed breast cancer treatment options with patients but many report gaps in their knowledge.
The stable structure of circRNA makes it an ideal candidate for biomarkers because it can be detected in blood or urine, making it potentially useful for cancer diagnosis or prognosis.
In a new paper, researchers and ethicists urge policymakers to view immortal cells differently from other biospecimens as new rules go into effect.
Breast cancer survivors reported improvements in depression, pain, anxiety and sleep after self-administered acupressure.
Newer genetic tests introduce more ambiguity, but a new study finds patients are not overreacting to uncertain results.
